ALICIA CARDEN: Open Payments
NPI 1942688403 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,492 in 101 payments from 12 companies in 2025. Trend: 2023 $352 · 2024 $1,789 · 2025 $1,492
Food & beverage: $1,492
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 15 | $255 |
| Otsuka America Pharmaceutical, Inc. | 29 | $229 |
| Teva Pharmaceuticals USA, Inc. | 18 | $188 |
| Neurocrine BioSciences, Inc. | 8 | $170 |
| Axsome Therapeutics, Inc. | 7 | $163 |
| Alkermes, Inc. | 8 | $142 |
| Janssen Pharmaceuticals, Inc | 5 | $107 |
| Vanda Pharmaceuticals Inc. | 3 | $67 |
| Lundbeck LLC | 3 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $57 |
Products named: COBENFY, REXULTI, INGREZZA, Auvelity, INVEGA, AUSTEDO XR, ARISTADA, ABILIFY MAINTENA.
Industry payments across FL — which companies pay providers there.
